International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3 , Pages 685-697, 1 March 2010

Postoperative Proton Radiotherapy for Localized and Locoregional Breast Cancer: Potential for Clinically Relevant Improvements?

Partially presented at the ASTRO 49th Annual Meeting, Los Angeles, CA, October 28–November 1, 2007.

  • Carmen Ares, M.D.

      Affiliations

    • Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
    • Corresponding Author InformationReprint requests to: Carmen Ares, Center for Proton Therapy, Paul Scherrer Institute, 5232-Villigen PSI, Switzerland. Tel: +41563105412; Fax: +41563103515
  • ,
  • Shaka Khan, B.Sc.

      Affiliations

    • Institute of Radiation Oncology, Canton Hospital, Aarau, Switzerland
  • ,
  • Anne M. MacArtain, M.Sc.

      Affiliations

    • Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
  • ,
  • Jürg Heuberger, M.D.

      Affiliations

    • Institute of Radiation Oncology, Canton Hospital, Aarau, Switzerland
  • ,
  • Gudrun Goitein, M.D.

      Affiliations

    • Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
  • ,
  • Guenther Gruber, M.D.

      Affiliations

    • Institute of Radiation Oncology, Canton Hospital, Aarau, Switzerland
  • ,
  • Gerd Lutters, Ph.D.

      Affiliations

    • Institute of Radiation Oncology, Canton Hospital, Aarau, Switzerland
  • ,
  • Eugen B. Hug, M.D.

      Affiliations

    • Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
  • ,
  • Stephan Bodis, M.D.

      Affiliations

    • Institute of Radiation Oncology, Canton Hospital, Aarau, Switzerland
  • ,
  • Antony J. Lomax, Ph.D.

      Affiliations

    • Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland

Received 3 December 2008; received in revised form 23 February 2009; accepted 24 February 2009. published online 16 July 2009.

Purpose

To study the potential reduction of dose to organs at risk (OARs) with intensity-modulated proton radiotherapy (IMPT) compared with intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3D-CRT) photon radiotherapy for left-sided breast cancer patients.

Methods and Materials

Comparative treatment-planning was performed using planning computed tomography scans of 20 left-sided breast cancer patients. For each patient, three increasingly complex locoregional volumes (planning target volumes [PTVs]) were defined: whole breast (WB) or chest wall (CW) = (PTV1), WB/CW plus medial-supraclavicular (MSC), lateral-supraclavicular (LSC), and level III axillary (AxIII) nodes = (PTV2) and WB/CW+MSC+LSC+AxIII plus internal mammary chain = (PTV3). For each patient, 3D-CRT, IMRT, and IMPT plans were optimized for PTV coverage. Dose to OARs was compared while maintaining target coverage.

Results

All the techniques met the required PTV coverage except the 3D-CRT plans for PTV3-scenario. All 3D-CRT plans for PTV3 exceeded left-lung V20. IMPT vs. 3D-CRT: significant dose reductions were observed for all OARs using IMPT for all PTVs. IMPT vs. IMRT: For PTV2 and PTV3, low (V5) left lung and cardiac doses were reduced by a factor >2.5, and cardiac doses (V22.5) were by a factor of >20 lower with IMPT compared with IMRT.

Conclusions

When complex-target irradiation is needed, 3D-CRT often compromises the target coverage and increases the dose to OARs; IMRT can provide better results but will increase the integral dose. The benefit of IMPT is based on improved target coverage and reduction of low doses to OARs, potentially reducing the risk of late-toxicity. These results indicate a potential role of proton-radiotherapy for extended locoregional irradiation in left breast cancer.

Proton therapy, Spot-scanning, IMRT, 3D-CRT, Breast cancer, Toxicity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by Onco-Suisse grant from the Swiss Federation Against Cancer.

 No author has economic gain or conflict of interest related to publication of this manuscript.

 Conflicts of Interest Notification

PII: S0360-3016(09)00365-4

doi:10.1016/j.ijrobp.2009.02.062

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3 , Pages 685-697, 1 March 2010